Market potential Target mid-sized pharmaceutical manufacturers and contract partners seeking value-added medicines and complex generics, leveraging SK Pharma’s patient-centric solutions and global reach to expand product portfolios.

Expansion readiness Position SK Pharma as a partner for new therapeutics introductions from registration to promotion and distribution, offering end-to-end support to accelerate market entry for unmet needs.

Tender leverage Capitalize on SK Pharma’s track record with government tenders and lobbying capabilities to win public sector opportunities, aligning portfolio with tender-driven procurement cycles.

Innovation emphasis Highlight opportunities around personalized and accessible medicines by proposing collaborations on value-added formulations, targeted therapies, and patient adherence solutions.

Financial and scale fit Engage SK Pharma as a growth partner given its revenue scale in the mid hundreds of millions and its global, multilingual operations, suitable for joint ventures, co-marketing, or regional expansion deals.